| |
| Alle Journale wurden nach Muschitz Ch durchsucht |
Treffer 1 - 4 von 4 |
|
|
|---|
1. Muschitz Ch;
Dimai H-P;
Kocijan R;
Kaider A;
Resch H
The Discriminatory Capacity of BMD Measurements by DXL at the Calcaneus and DXA at the Hip and Spine Including Clinical Risk Factors to Detecting Patients with Vertebral Fractures
BMD-Measurements
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 2013; 20 (2): 52-56
Delineation of improvement in prediction of fracture by combination of BMD measurement with CRF according to the FRAX®; AUC for DXA = BMD femoral neck; AUC for DXL = BMD calcaneus; graphs show different BMD measurements; (A) ROC of CRF without BMD measurement, (B) ROC curves of CRF and BMD measurements (DXA femoral neck/DXL calcaneus). Keywords: BMD Measurements,
BMD-Messungen,
CRF,
CRF,
diagram,
Diagramm,
DXA,
DXA,
DXL,
DXL,
Mineralstoffwechsel,
Osteoporose,
osteoporosis
|
|
|
2. Muschitz Ch;
Dimai H-P;
Kocijan R;
Kaider A;
Resch H
The Discriminatory Capacity of BMD Measurements by DXL at the Calcaneus and DXA at the Hip and Spine Including Clinical Risk Factors to Detecting Patients with Vertebral Fractures
BMD-Measurements
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 2013; 20 (2): 52-56
Receiver operating characteristic (ROC) curves of all BMD measurements: DXA femoral neck = 0.670, DXL calcaneus = 0.665, DXA total hip = 0.661, DXA lumbar spine = 0.598; p = 0.04 for comparison of DXA at lumbar spine and DXL at
calcaneus. Keywords: BMD Measurements,
BMD-Messungen,
diagram,
Diagramm,
DXA,
DXA,
DXL,
DXL,
Mineralstoffwechsel,
Osteoporose,
osteoporosis,
ROC,
ROC
|
|
|
3. Muschitz Ch;
Dimai H-P;
Kocijan R;
Kaider A;
Resch H
The Discriminatory Capacity of BMD Measurements by DXL at the Calcaneus and DXA at the Hip and Spine Including Clinical Risk Factors to Detecting Patients with Vertebral Fractures
BMD-Measurements
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 2013; 20 (2): 52-56
Patient flow diagram Keywords: BMD Measurements,
BMD-Messungen,
flowchart,
Flussdiagramm,
Mineralstoffwechsel,
Osteoporose,
osteoporosis
|
|
|
4. Muschitz Ch
Der RANKL-Inhibitor als neue Therapie gegen Frakturen
Signifikante Fraktursenkung
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 2011; 18 (2): 69-71
Signifikante Fraktursenkung na ch 3-jähriger Denosumab-Therapie.
(Mod. nach [16]). Keywords: Denosumab-Therapie,
Mineralstoffwechsel,
nach 3 Jahren,
signifikaten Fraktursenkung,
Statistik
|
|
|
| |
|
Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
